John Rinn
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Long Noncoding | 61 | 2023 | 157 | 17.460 |
Why?
| RNA, Untranslated | 27 | 2021 | 113 | 6.490 |
Why?
| Gene Expression Regulation | 48 | 2021 | 2353 | 4.730 |
Why?
| Chromatin | 26 | 2023 | 429 | 4.230 |
Why?
| RNA | 16 | 2022 | 820 | 2.950 |
Why?
| Cell Nucleus | 13 | 2023 | 553 | 2.600 |
Why?
| Genome | 12 | 2022 | 271 | 2.440 |
Why?
| Genome, Human | 18 | 2021 | 352 | 2.380 |
Why?
| RNA, Messenger | 25 | 2021 | 2574 | 2.150 |
Why?
| Enhancer Elements, Genetic | 10 | 2020 | 150 | 2.120 |
Why?
| Promoter Regions, Genetic | 16 | 2021 | 1122 | 2.100 |
Why?
| Tumor Suppressor Protein p53 | 8 | 2017 | 449 | 2.030 |
Why?
| Transcription, Genetic | 28 | 2020 | 1310 | 2.020 |
Why?
| RNA-Binding Proteins | 14 | 2020 | 362 | 1.870 |
Why?
| Repetitive Sequences, Nucleic Acid | 3 | 2021 | 104 | 1.770 |
Why?
| Models, Genetic | 8 | 2018 | 570 | 1.720 |
Why?
| Epigenesis, Genetic | 16 | 2021 | 526 | 1.690 |
Why?
| Sequence Analysis, RNA | 14 | 2019 | 391 | 1.530 |
Why?
| Cell Differentiation | 25 | 2023 | 1700 | 1.520 |
Why?
| Telomerase | 3 | 2021 | 206 | 1.410 |
Why?
| Gene Deletion | 6 | 2021 | 355 | 1.410 |
Why?
| Animals | 90 | 2023 | 32104 | 1.400 |
Why?
| Transcriptome | 11 | 2020 | 736 | 1.400 |
Why?
| Fibroblasts | 10 | 2018 | 839 | 1.310 |
Why?
| CCCTC-Binding Factor | 2 | 2018 | 12 | 1.250 |
Why?
| Mice | 58 | 2022 | 15052 | 1.220 |
Why?
| Genomics | 13 | 2022 | 646 | 1.220 |
Why?
| Base Sequence | 18 | 2020 | 2114 | 1.200 |
Why?
| X Chromosome Inactivation | 5 | 2020 | 21 | 1.170 |
Why?
| Chromosomes | 3 | 2018 | 85 | 1.150 |
Why?
| DNA, Complementary | 8 | 2020 | 258 | 1.140 |
Why?
| Embryonic Stem Cells | 10 | 2015 | 105 | 1.120 |
Why?
| Genetic Loci | 7 | 2020 | 264 | 1.100 |
Why?
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 25 | 1.100 |
Why?
| Gene Expression Regulation, Developmental | 16 | 2023 | 794 | 1.020 |
Why?
| Transcription Factors | 17 | 2020 | 1528 | 0.990 |
Why?
| Gene Expression Profiling | 29 | 2020 | 1537 | 0.970 |
Why?
| Molecular Sequence Annotation | 7 | 2020 | 82 | 0.960 |
Why?
| Open Reading Frames | 7 | 2020 | 116 | 0.960 |
Why?
| Hematopoiesis | 3 | 2021 | 173 | 0.940 |
Why?
| Humans | 117 | 2023 | 115741 | 0.920 |
Why?
| DNA Damage | 2 | 2017 | 357 | 0.920 |
Why?
| Induced Pluripotent Stem Cells | 7 | 2021 | 183 | 0.910 |
Why?
| Mice, Knockout | 13 | 2020 | 2604 | 0.890 |
Why?
| RNA Splicing | 6 | 2021 | 244 | 0.830 |
Why?
| Fertility | 2 | 2020 | 131 | 0.830 |
Why?
| Microscopy, Confocal | 3 | 2018 | 299 | 0.810 |
Why?
| Pluripotent Stem Cells | 6 | 2022 | 63 | 0.810 |
Why?
| Computational Biology | 7 | 2021 | 537 | 0.810 |
Why?
| Regulatory Elements, Transcriptional | 4 | 2020 | 15 | 0.790 |
Why?
| Polycomb Repressive Complex 2 | 5 | 2020 | 59 | 0.770 |
Why?
| Ebolavirus | 4 | 2023 | 34 | 0.760 |
Why?
| Hemorrhagic Fever, Ebola | 4 | 2023 | 33 | 0.750 |
Why?
| Binding Sites | 12 | 2020 | 1177 | 0.750 |
Why?
| Cellular Reprogramming | 4 | 2018 | 84 | 0.740 |
Why?
| Cytoplasm | 3 | 2022 | 255 | 0.730 |
Why?
| Cell Line | 16 | 2021 | 2651 | 0.730 |
Why?
| Evolution, Molecular | 4 | 2020 | 440 | 0.730 |
Why?
| Sequence Deletion | 3 | 2020 | 167 | 0.720 |
Why?
| DNA | 7 | 2022 | 1356 | 0.710 |
Why?
| Body Patterning | 4 | 2008 | 126 | 0.700 |
Why?
| Polymorphism, Single Nucleotide | 6 | 2020 | 1919 | 0.680 |
Why?
| DNA-Binding Proteins | 7 | 2021 | 1316 | 0.680 |
Why?
| Repressor Proteins | 7 | 2018 | 369 | 0.670 |
Why?
| K562 Cells | 5 | 2021 | 73 | 0.670 |
Why?
| Embryonic Development | 6 | 2019 | 115 | 0.670 |
Why?
| Oligonucleotide Array Sequence Analysis | 17 | 2016 | 746 | 0.650 |
Why?
| In Situ Hybridization, Fluorescence | 7 | 2021 | 310 | 0.640 |
Why?
| Nucleic Acid Conformation | 6 | 2022 | 672 | 0.640 |
Why?
| Organ Specificity | 6 | 2019 | 273 | 0.630 |
Why?
| DNA Methylation | 8 | 2022 | 499 | 0.630 |
Why?
| Alleles | 5 | 2020 | 794 | 0.620 |
Why?
| Endogenous Retroviruses | 2 | 2022 | 19 | 0.620 |
Why?
| Sequence Analysis, DNA | 3 | 2016 | 732 | 0.620 |
Why?
| Protein Biosynthesis | 1 | 2020 | 390 | 0.610 |
Why?
| Chromosomes, Human | 1 | 2018 | 39 | 0.610 |
Why?
| Time-Lapse Imaging | 1 | 2018 | 19 | 0.610 |
Why?
| Chromosome Aberrations | 1 | 2018 | 134 | 0.610 |
Why?
| Molecular Sequence Data | 10 | 2015 | 2790 | 0.610 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 60 | 0.610 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 1147 | 0.590 |
Why?
| Neoplasms | 5 | 2019 | 2118 | 0.550 |
Why?
| Gene Regulatory Networks | 7 | 2018 | 231 | 0.550 |
Why?
| High-Throughput Nucleotide Sequencing | 6 | 2018 | 443 | 0.550 |
Why?
| Homeodomain Proteins | 6 | 2013 | 465 | 0.530 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.530 |
Why?
| Ribonucleoproteins | 3 | 2012 | 87 | 0.520 |
Why?
| DNA, Satellite | 1 | 2015 | 16 | 0.520 |
Why?
| DNA, Intergenic | 4 | 2011 | 23 | 0.520 |
Why?
| Centromere | 1 | 2015 | 42 | 0.510 |
Why?
| Plasmodium falciparum | 2 | 2015 | 27 | 0.510 |
Why?
| Genes, Homeobox | 5 | 2013 | 50 | 0.500 |
Why?
| Nuclear Proteins | 3 | 2016 | 594 | 0.470 |
Why?
| DNA Transposable Elements | 1 | 2014 | 100 | 0.460 |
Why?
| Systems Biology | 3 | 2011 | 57 | 0.440 |
Why?
| HeLa Cells | 8 | 2021 | 567 | 0.440 |
Why?
| Myoblasts | 3 | 2022 | 74 | 0.440 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 114 | 0.430 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2014 | 135 | 0.430 |
Why?
| Protein Binding | 11 | 2020 | 1917 | 0.430 |
Why?
| Brain | 2 | 2015 | 2373 | 0.430 |
Why?
| RNA Interference | 7 | 2021 | 438 | 0.420 |
Why?
| HEK293 Cells | 7 | 2021 | 602 | 0.420 |
Why?
| Skin | 2 | 2008 | 662 | 0.420 |
Why?
| Phenotype | 7 | 2021 | 2839 | 0.420 |
Why?
| Homeostasis | 4 | 2021 | 577 | 0.420 |
Why?
| Adipogenesis | 1 | 2013 | 42 | 0.420 |
Why?
| Retroelements | 1 | 2012 | 39 | 0.420 |
Why?
| Cells, Cultured | 16 | 2021 | 3914 | 0.410 |
Why?
| Epidermis | 2 | 2012 | 149 | 0.380 |
Why?
| RNA Stability | 5 | 2021 | 93 | 0.380 |
Why?
| Introns | 5 | 2021 | 226 | 0.380 |
Why?
| Human Embryonic Stem Cells | 2 | 2021 | 18 | 0.380 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 2023 | 78 | 0.370 |
Why?
| Histones | 11 | 2021 | 540 | 0.370 |
Why?
| Single-Cell Analysis | 5 | 2020 | 188 | 0.370 |
Why?
| Telomere | 2 | 2019 | 204 | 0.360 |
Why?
| Conserved Sequence | 6 | 2020 | 219 | 0.360 |
Why?
| Down-Regulation | 3 | 2016 | 601 | 0.350 |
Why?
| Sex Characteristics | 2 | 2005 | 641 | 0.350 |
Why?
| Mouse Embryonic Stem Cells | 3 | 2020 | 22 | 0.350 |
Why?
| Muscle Development | 3 | 2022 | 93 | 0.350 |
Why?
| Chromosomes, Human, Pair 22 | 4 | 2004 | 39 | 0.340 |
Why?
| Gene Library | 4 | 2018 | 117 | 0.340 |
Why?
| Gene Editing | 2 | 2021 | 59 | 0.340 |
Why?
| CRISPR-Cas Systems | 3 | 2021 | 81 | 0.330 |
Why?
| MicroRNAs | 8 | 2021 | 607 | 0.330 |
Why?
| Mammals | 5 | 2021 | 251 | 0.320 |
Why?
| Antineoplastic Agents | 1 | 2019 | 1893 | 0.320 |
Why?
| Nucleotide Motifs | 3 | 2017 | 30 | 0.310 |
Why?
| Immunity, Innate | 3 | 2019 | 731 | 0.310 |
Why?
| Cell Lineage | 5 | 2021 | 310 | 0.300 |
Why?
| Lymphopoiesis | 2 | 2021 | 24 | 0.290 |
Why?
| Chromatin Assembly and Disassembly | 5 | 2017 | 91 | 0.290 |
Why?
| Colorectal Neoplasms | 1 | 2014 | 617 | 0.290 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 27 | 0.290 |
Why?
| Genomic Imprinting | 2 | 2021 | 32 | 0.280 |
Why?
| Reproducibility of Results | 6 | 2021 | 2824 | 0.280 |
Why?
| Wnt Proteins | 1 | 2008 | 135 | 0.280 |
Why?
| Proteins | 6 | 2018 | 920 | 0.280 |
Why?
| DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 14 | 0.270 |
Why?
| HCT116 Cells | 3 | 2021 | 69 | 0.260 |
Why?
| MAP Kinase Signaling System | 1 | 2007 | 275 | 0.260 |
Why?
| Male | 20 | 2020 | 56050 | 0.260 |
Why?
| Exons | 4 | 2016 | 300 | 0.260 |
Why?
| Databases, Genetic | 4 | 2020 | 208 | 0.250 |
Why?
| Signal Transduction | 11 | 2021 | 4541 | 0.240 |
Why?
| Myosin Heavy Chains | 2 | 2021 | 169 | 0.240 |
Why?
| Drug Resistance, Neoplasm | 2 | 2019 | 638 | 0.240 |
Why?
| Motor Neurons | 3 | 2015 | 213 | 0.240 |
Why?
| Proto-Oncogene Proteins | 1 | 2008 | 609 | 0.230 |
Why?
| Genitalia | 1 | 2004 | 28 | 0.230 |
Why?
| Gene Knockdown Techniques | 4 | 2013 | 302 | 0.230 |
Why?
| Hemorrhagic Fevers, Viral | 1 | 2023 | 3 | 0.230 |
Why?
| Female | 22 | 2023 | 60018 | 0.220 |
Why?
| Alternative Splicing | 2 | 2018 | 187 | 0.220 |
Why?
| Zebrafish | 4 | 2013 | 412 | 0.220 |
Why?
| Cluster Analysis | 5 | 2015 | 465 | 0.220 |
Why?
| Databases, Nucleic Acid | 2 | 2021 | 33 | 0.210 |
Why?
| Plasmids | 1 | 2023 | 345 | 0.210 |
Why?
| NF-kappa B | 4 | 2020 | 639 | 0.210 |
Why?
| Mitosis | 2 | 2021 | 164 | 0.210 |
Why?
| Pharmaceutical Preparations | 1 | 2004 | 169 | 0.200 |
Why?
| X Chromosome | 2 | 2020 | 47 | 0.200 |
Why?
| RNA Transport | 3 | 2016 | 22 | 0.200 |
Why?
| Ribonucleases | 2 | 2019 | 53 | 0.200 |
Why?
| Genetic Techniques | 2 | 2013 | 57 | 0.190 |
Why?
| Gene Targeting | 1 | 2021 | 75 | 0.190 |
Why?
| Ectoderm | 1 | 2021 | 43 | 0.190 |
Why?
| Mice, Inbred Strains | 2 | 2019 | 399 | 0.190 |
Why?
| Cell Compartmentation | 1 | 2021 | 52 | 0.190 |
Why?
| Muscle Fibers, Skeletal | 2 | 2022 | 169 | 0.190 |
Why?
| Genetic Association Studies | 3 | 2014 | 345 | 0.190 |
Why?
| Stem Cells | 3 | 2022 | 546 | 0.190 |
Why?
| Research Report | 1 | 2021 | 76 | 0.190 |
Why?
| Placenta | 3 | 2021 | 624 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 930 | 0.190 |
Why?
| Cardiac Myosins | 1 | 2021 | 29 | 0.190 |
Why?
| Ikaros Transcription Factor | 1 | 2021 | 18 | 0.190 |
Why?
| Receptor, Insulin | 1 | 2021 | 93 | 0.180 |
Why?
| Lipopolysaccharides | 3 | 2019 | 826 | 0.180 |
Why?
| Spermatogenesis | 1 | 2020 | 52 | 0.180 |
Why?
| Protein Domains | 2 | 2020 | 209 | 0.180 |
Why?
| Epigenomics | 2 | 2011 | 105 | 0.180 |
Why?
| Polycomb-Group Proteins | 3 | 2010 | 29 | 0.180 |
Why?
| Telomere Homeostasis | 1 | 2020 | 24 | 0.180 |
Why?
| Eukaryotic Cells | 1 | 2020 | 33 | 0.180 |
Why?
| RNA Precursors | 1 | 2021 | 136 | 0.180 |
Why?
| Congresses as Topic | 1 | 2021 | 204 | 0.180 |
Why?
| Genome-Wide Association Study | 4 | 2020 | 1218 | 0.170 |
Why?
| Species Specificity | 1 | 2021 | 552 | 0.170 |
Why?
| Preimplantation Diagnosis | 1 | 2019 | 4 | 0.170 |
Why?
| SOXB1 Transcription Factors | 1 | 2020 | 60 | 0.170 |
Why?
| Embryo Implantation | 1 | 2019 | 23 | 0.170 |
Why?
| Dactinomycin | 1 | 2019 | 25 | 0.170 |
Why?
| RNA Processing, Post-Transcriptional | 3 | 2018 | 81 | 0.170 |
Why?
| Cell Line, Tumor | 4 | 2021 | 2751 | 0.170 |
Why?
| Drug Tolerance | 1 | 2019 | 79 | 0.170 |
Why?
| Fertilization in Vitro | 1 | 2019 | 71 | 0.160 |
Why?
| Organelles | 2 | 2017 | 51 | 0.160 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 511 | 0.160 |
Why?
| RNA, Fungal | 2 | 2010 | 65 | 0.160 |
Why?
| Apoptosis | 4 | 2018 | 2377 | 0.160 |
Why?
| Cell Proliferation | 7 | 2020 | 2194 | 0.160 |
Why?
| Protein Conformation | 2 | 2021 | 822 | 0.160 |
Why?
| Pattern Recognition, Automated | 1 | 2019 | 71 | 0.160 |
Why?
| Transgenes | 3 | 2020 | 169 | 0.160 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2018 | 21 | 0.160 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2018 | 27 | 0.160 |
Why?
| Adipocytes | 1 | 2020 | 188 | 0.160 |
Why?
| Binding, Competitive | 2 | 2020 | 200 | 0.160 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2018 | 57 | 0.160 |
Why?
| HMGA2 Protein | 1 | 2018 | 8 | 0.150 |
Why?
| Macaca mulatta | 3 | 2023 | 132 | 0.150 |
Why?
| Molecular Imaging | 1 | 2018 | 52 | 0.150 |
Why?
| Lymphocytes | 2 | 2017 | 344 | 0.150 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 274 | 0.150 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 219 | 0.150 |
Why?
| Cell Nucleolus | 1 | 2018 | 17 | 0.150 |
Why?
| Cell Transformation, Neoplastic | 2 | 2017 | 314 | 0.150 |
Why?
| Translocation, Genetic | 1 | 2018 | 93 | 0.150 |
Why?
| Cyclooxygenase 2 | 1 | 2018 | 164 | 0.150 |
Why?
| Immunity | 1 | 2018 | 124 | 0.150 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 296 | 0.150 |
Why?
| Mice, Inbred C57BL | 9 | 2020 | 4773 | 0.150 |
Why?
| Bone Morphogenetic Proteins | 1 | 2018 | 133 | 0.150 |
Why?
| Consensus Sequence | 2 | 2016 | 70 | 0.150 |
Why?
| Pyramidal Tracts | 2 | 2014 | 20 | 0.150 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 58 | 0.150 |
Why?
| High-Throughput Screening Assays | 2 | 2016 | 124 | 0.150 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 246 | 0.150 |
Why?
| Staining and Labeling | 1 | 2017 | 139 | 0.140 |
Why?
| Kidney | 1 | 2004 | 1207 | 0.140 |
Why?
| Splicing Factor U2AF | 1 | 2016 | 16 | 0.140 |
Why?
| Genetic Testing | 1 | 2019 | 382 | 0.140 |
Why?
| Bcl-2-Like Protein 11 | 1 | 2016 | 38 | 0.140 |
Why?
| Genotype | 1 | 2021 | 1787 | 0.140 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 76 | 0.140 |
Why?
| Histone Deacetylases | 1 | 2018 | 196 | 0.140 |
Why?
| Mutation | 5 | 2018 | 3364 | 0.140 |
Why?
| HLA-G Antigens | 1 | 2016 | 1 | 0.140 |
Why?
| Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.140 |
Why?
| Image Processing, Computer-Assisted | 2 | 2018 | 699 | 0.130 |
Why?
| Liver | 1 | 2004 | 1690 | 0.130 |
Why?
| Support Vector Machine | 1 | 2016 | 35 | 0.130 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2016 | 7 | 0.130 |
Why?
| Doxorubicin | 1 | 2017 | 290 | 0.130 |
Why?
| Chromatin Assembly Factor-1 | 1 | 2015 | 9 | 0.130 |
Why?
| Active Transport, Cell Nucleus | 1 | 2016 | 111 | 0.130 |
Why?
| PTEN Phosphohydrolase | 2 | 2016 | 142 | 0.130 |
Why?
| Myocardium | 1 | 2021 | 926 | 0.130 |
Why?
| Methylation | 5 | 2020 | 206 | 0.130 |
Why?
| Erythrocytes | 1 | 2020 | 589 | 0.130 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 18 | 0.130 |
Why?
| Linkage Disequilibrium | 1 | 2016 | 247 | 0.130 |
Why?
| Chondrocytes | 1 | 2018 | 199 | 0.130 |
Why?
| Nervous System | 1 | 2015 | 63 | 0.130 |
Why?
| rho GTP-Binding Proteins | 1 | 2016 | 62 | 0.130 |
Why?
| Muscular Atrophy, Spinal | 1 | 2015 | 17 | 0.130 |
Why?
| Pseudogenes | 2 | 2014 | 18 | 0.130 |
Why?
| Immunohistochemistry | 3 | 2015 | 1642 | 0.130 |
Why?
| beta-Galactosidase | 1 | 2015 | 63 | 0.130 |
Why?
| Myeloid Cells | 1 | 2016 | 127 | 0.130 |
Why?
| Gene Expression | 4 | 2015 | 1436 | 0.130 |
Why?
| Genes | 1 | 2015 | 224 | 0.130 |
Why?
| Neurons | 2 | 2021 | 1298 | 0.120 |
Why?
| STAT3 Transcription Factor | 1 | 2016 | 174 | 0.120 |
Why?
| RNA, Protozoan | 1 | 2015 | 57 | 0.120 |
Why?
| Gene Silencing | 2 | 2013 | 175 | 0.120 |
Why?
| Maternal-Fetal Exchange | 1 | 2016 | 151 | 0.120 |
Why?
| Hematopoietic Stem Cells | 1 | 2018 | 346 | 0.120 |
Why?
| Lysine | 3 | 2020 | 246 | 0.120 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 92 | 0.120 |
Why?
| Pregnancy | 4 | 2023 | 5553 | 0.120 |
Why?
| Pyramidal Cells | 1 | 2014 | 51 | 0.120 |
Why?
| Protein-Tyrosine Kinases | 1 | 2018 | 396 | 0.120 |
Why?
| Neocortex | 1 | 2014 | 25 | 0.120 |
Why?
| RNA, Catalytic | 1 | 2015 | 182 | 0.120 |
Why?
| Molecular Biology | 1 | 2015 | 56 | 0.120 |
Why?
| Kinetics | 1 | 2018 | 1569 | 0.120 |
Why?
| Leukemia, Myeloid, Acute | 2 | 2018 | 538 | 0.120 |
Why?
| Trophoblasts | 1 | 2016 | 162 | 0.120 |
Why?
| Protein Footprinting | 1 | 2014 | 9 | 0.120 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2020 | 965 | 0.120 |
Why?
| Neurotransmitter Agents | 1 | 2014 | 77 | 0.120 |
Why?
| Keratinocytes | 2 | 2012 | 215 | 0.110 |
Why?
| Neuronal Plasticity | 1 | 2015 | 214 | 0.110 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 34 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 501 | 0.110 |
Why?
| Immunoprecipitation | 1 | 2014 | 154 | 0.110 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2011 | 150 | 0.110 |
Why?
| Nerve Tissue Proteins | 2 | 2014 | 535 | 0.110 |
Why?
| Fetus | 1 | 2017 | 702 | 0.110 |
Why?
| Information Theory | 1 | 2013 | 4 | 0.110 |
Why?
| Nervous System Diseases | 1 | 2015 | 253 | 0.110 |
Why?
| Registries | 1 | 2020 | 1770 | 0.100 |
Why?
| Ubiquitination | 1 | 2013 | 86 | 0.100 |
Why?
| Natural Killer T-Cells | 1 | 2013 | 63 | 0.100 |
Why?
| Protein Array Analysis | 1 | 2012 | 60 | 0.100 |
Why?
| Mice, Transgenic | 5 | 2020 | 1970 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1646 | 0.100 |
Why?
| Adipocytes, Brown | 1 | 2012 | 6 | 0.100 |
Why?
| Ribosomes | 1 | 2013 | 148 | 0.100 |
Why?
| Adipocytes, White | 1 | 2012 | 17 | 0.100 |
Why?
| Mitochondria | 2 | 2020 | 750 | 0.100 |
Why?
| Genes, Overlapping | 1 | 2011 | 2 | 0.100 |
Why?
| Biological Evolution | 1 | 2015 | 417 | 0.100 |
Why?
| Genome, Protozoan | 1 | 2011 | 1 | 0.100 |
Why?
| Genes, Protozoan | 1 | 2011 | 10 | 0.100 |
Why?
| Disease | 1 | 2012 | 87 | 0.090 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.090 |
Why?
| Artifacts | 1 | 2011 | 123 | 0.090 |
Why?
| Insulin | 2 | 2018 | 2082 | 0.090 |
Why?
| Colonic Neoplasms | 1 | 2013 | 222 | 0.090 |
Why?
| Sequence Alignment | 1 | 2011 | 327 | 0.090 |
Why?
| Argonaute Proteins | 3 | 2016 | 28 | 0.090 |
Why?
| Sexual Maturation | 1 | 2010 | 47 | 0.090 |
Why?
| Octamer Transcription Factor-3 | 2 | 2021 | 16 | 0.090 |
Why?
| Body Size | 1 | 2010 | 92 | 0.090 |
Why?
| Adenocarcinoma | 1 | 2016 | 799 | 0.080 |
Why?
| Saccharomyces cerevisiae | 2 | 2010 | 482 | 0.080 |
Why?
| Thymus Gland | 2 | 2008 | 299 | 0.080 |
Why?
| Proteome | 1 | 2012 | 345 | 0.080 |
Why?
| Prostatic Neoplasms | 1 | 2016 | 927 | 0.080 |
Why?
| Zebrafish Proteins | 2 | 2010 | 246 | 0.080 |
Why?
| Chromosome Mapping | 3 | 2004 | 489 | 0.080 |
Why?
| Drosophila melanogaster | 1 | 2010 | 190 | 0.080 |
Why?
| Viruses | 1 | 2009 | 94 | 0.080 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 63 | 0.080 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.080 |
Why?
| Bone Marrow Cells | 1 | 2009 | 268 | 0.080 |
Why?
| Wnt-5a Protein | 1 | 2008 | 19 | 0.080 |
Why?
| Myosin Type V | 1 | 2008 | 9 | 0.080 |
Why?
| Chromosome Disorders | 1 | 2008 | 34 | 0.080 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 526 | 0.080 |
Why?
| Software | 1 | 2012 | 541 | 0.070 |
Why?
| Amino Acid Sequence | 2 | 2020 | 2000 | 0.070 |
Why?
| Breast Neoplasms | 2 | 2016 | 1872 | 0.070 |
Why?
| Cell Survival | 3 | 2016 | 1024 | 0.070 |
Why?
| Keratins | 1 | 2008 | 176 | 0.070 |
Why?
| Genes, Reporter | 2 | 2020 | 257 | 0.070 |
Why?
| Autoantigens | 2 | 2008 | 398 | 0.070 |
Why?
| Peptides | 1 | 2012 | 864 | 0.070 |
Why?
| Bacteria | 2 | 2013 | 729 | 0.070 |
Why?
| Zinc Fingers | 1 | 2007 | 44 | 0.070 |
Why?
| Wound Healing | 1 | 2009 | 257 | 0.070 |
Why?
| Retinol-Binding Proteins | 1 | 2006 | 13 | 0.070 |
Why?
| Epithelium | 1 | 2008 | 297 | 0.070 |
Why?
| Protozoan Proteins | 1 | 2007 | 62 | 0.070 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 157 | 0.070 |
Why?
| Algorithms | 1 | 2014 | 1500 | 0.070 |
Why?
| ras Proteins | 1 | 2007 | 138 | 0.070 |
Why?
| Eye Proteins | 1 | 2006 | 73 | 0.070 |
Why?
| Dendritic Cells | 1 | 2009 | 438 | 0.070 |
Why?
| Monocytes | 2 | 2020 | 507 | 0.060 |
Why?
| Up-Regulation | 2 | 2020 | 820 | 0.060 |
Why?
| RNA, Small Interfering | 2 | 2021 | 544 | 0.060 |
Why?
| Tissue Distribution | 1 | 2006 | 324 | 0.060 |
Why?
| Neoplastic Stem Cells | 1 | 2009 | 331 | 0.060 |
Why?
| Quantitative Trait Loci | 2 | 2020 | 313 | 0.060 |
Why?
| RNA Polymerase II | 2 | 2023 | 283 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 336 | 0.060 |
Why?
| Transcortin | 1 | 2004 | 20 | 0.060 |
Why?
| Serpins | 1 | 2004 | 27 | 0.060 |
Why?
| Metabolic Clearance Rate | 1 | 2004 | 108 | 0.060 |
Why?
| Testis | 1 | 2004 | 134 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 128 | 0.060 |
Why?
| Hypothalamus | 1 | 2004 | 150 | 0.060 |
Why?
| Virus Internalization | 1 | 2023 | 41 | 0.050 |
Why?
| Autoimmune Diseases | 1 | 2006 | 395 | 0.050 |
Why?
| Selection, Genetic | 1 | 2005 | 243 | 0.050 |
Why?
| SOXF Transcription Factors | 1 | 2023 | 18 | 0.050 |
Why?
| Endoderm | 1 | 2023 | 19 | 0.050 |
Why?
| Chromatin Immunoprecipitation | 2 | 2016 | 129 | 0.050 |
Why?
| Poly A | 1 | 2003 | 46 | 0.050 |
Why?
| Macrophages | 2 | 2020 | 1284 | 0.050 |
Why?
| Ovary | 1 | 2004 | 190 | 0.050 |
Why?
| Models, Statistical | 1 | 2006 | 606 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2016 | 445 | 0.050 |
Why?
| Terminal Repeat Sequences | 1 | 2022 | 14 | 0.050 |
Why?
| Receptors, Cell Surface | 1 | 2004 | 356 | 0.050 |
Why?
| Cytoskeletal Proteins | 2 | 2012 | 145 | 0.050 |
Why?
| Disease Models, Animal | 4 | 2017 | 3580 | 0.050 |
Why?
| Histone Demethylases | 2 | 2015 | 28 | 0.050 |
Why?
| Time Factors | 3 | 2020 | 6171 | 0.050 |
Why?
| RNA, Small Untranslated | 1 | 2021 | 15 | 0.050 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2023 | 167 | 0.050 |
Why?
| Diabetes Mellitus | 1 | 2009 | 908 | 0.050 |
Why?
| Primates | 1 | 2022 | 111 | 0.050 |
Why?
| Myelopoiesis | 1 | 2020 | 6 | 0.050 |
Why?
| Smad1 Protein | 1 | 2020 | 18 | 0.050 |
Why?
| Oligonucleotide Probes | 2 | 2015 | 54 | 0.050 |
Why?
| Cochlear Nucleus | 1 | 2000 | 5 | 0.050 |
Why?
| Gene Ontology | 1 | 2020 | 47 | 0.050 |
Why?
| Bystander Effect | 1 | 2020 | 15 | 0.050 |
Why?
| DNA Replication Timing | 1 | 2020 | 1 | 0.050 |
Why?
| Transposases | 1 | 2020 | 9 | 0.050 |
Why?
| Forkhead Transcription Factors | 1 | 2021 | 171 | 0.050 |
Why?
| DNA Footprinting | 1 | 2020 | 28 | 0.050 |
Why?
| Deoxyribonuclease I | 1 | 2020 | 34 | 0.050 |
Why?
| CpG Islands | 2 | 2015 | 118 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.040 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2000 | 48 | 0.040 |
Why?
| Gene Expression Regulation, Viral | 1 | 2020 | 80 | 0.040 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 165 | 0.040 |
Why?
| Cell Respiration | 1 | 2020 | 74 | 0.040 |
Why?
| Genetic Variation | 1 | 2005 | 880 | 0.040 |
Why?
| Potassium Channels | 1 | 2000 | 121 | 0.040 |
Why?
| Static Electricity | 1 | 2020 | 117 | 0.040 |
Why?
| Karyotype | 1 | 2019 | 13 | 0.040 |
Why?
| Interferons | 1 | 2020 | 152 | 0.040 |
Why?
| Karyotyping | 1 | 2019 | 102 | 0.040 |
Why?
| Blastocyst | 1 | 2019 | 43 | 0.040 |
Why?
| Molecular Dynamics Simulation | 1 | 2021 | 209 | 0.040 |
Why?
| Cell Movement | 2 | 2016 | 867 | 0.040 |
Why?
| Histocompatibility Antigens Class II | 1 | 2020 | 353 | 0.040 |
Why?
| Inflammation | 1 | 2009 | 2500 | 0.040 |
Why?
| Drug Delivery Systems | 1 | 2021 | 301 | 0.040 |
Why?
| Flow Cytometry | 2 | 2014 | 1083 | 0.040 |
Why?
| Interphase | 1 | 2018 | 32 | 0.040 |
Why?
| Internet | 1 | 2003 | 602 | 0.040 |
Why?
| HL-60 Cells | 1 | 2018 | 27 | 0.040 |
Why?
| Regenerative Medicine | 1 | 2018 | 41 | 0.040 |
Why?
| Genes, Switch | 1 | 2018 | 5 | 0.040 |
Why?
| Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 11 | 0.040 |
Why?
| Antigens, CD | 1 | 2020 | 442 | 0.040 |
Why?
| Chromosome Deletion | 1 | 2018 | 95 | 0.040 |
Why?
| GATA4 Transcription Factor | 1 | 2018 | 17 | 0.040 |
Why?
| Biotinylation | 1 | 2017 | 29 | 0.040 |
Why?
| Cytarabine | 1 | 2018 | 52 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2018 | 61 | 0.040 |
Why?
| A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
| Inhibitor of Differentiation Protein 2 | 1 | 2017 | 4 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2018 | 69 | 0.040 |
Why?
| STAT5 Transcription Factor | 1 | 2017 | 44 | 0.040 |
Why?
| Lymphocyte Subsets | 1 | 2017 | 79 | 0.040 |
Why?
| Oncogene Protein pp60(v-src) | 1 | 2016 | 5 | 0.040 |
Why?
| Lipid Metabolism | 1 | 2020 | 449 | 0.040 |
Why?
| Myocytes, Cardiac | 1 | 2021 | 457 | 0.040 |
Why?
| Pharmacogenetics | 1 | 2018 | 151 | 0.040 |
Why?
| Spleen | 1 | 2018 | 492 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2020 | 924 | 0.030 |
Why?
| Mice, Nude | 2 | 2010 | 639 | 0.030 |
Why?
| Phosphorylation | 1 | 2021 | 1571 | 0.030 |
Why?
| Macaca | 1 | 2016 | 51 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2016 | 105 | 0.030 |
Why?
| Antigens, Ly | 1 | 2016 | 45 | 0.030 |
Why?
| Mammary Glands, Human | 1 | 2016 | 60 | 0.030 |
Why?
| Immunogenetic Phenomena | 1 | 2016 | 6 | 0.030 |
Why?
| Lipids | 1 | 2020 | 588 | 0.030 |
Why?
| Cell Fractionation | 1 | 2016 | 53 | 0.030 |
Why?
| Carrier Proteins | 1 | 2020 | 701 | 0.030 |
Why?
| RNA Polymerase III | 1 | 2016 | 25 | 0.030 |
Why?
| Biopsy | 1 | 2019 | 1056 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2010 | 1168 | 0.030 |
Why?
| Mice, Inbred NOD | 2 | 2008 | 560 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 190 | 0.030 |
Why?
| Heterochromatin | 1 | 2015 | 35 | 0.030 |
Why?
| Transduction, Genetic | 1 | 2015 | 114 | 0.030 |
Why?
| Transcriptional Activation | 2 | 2010 | 340 | 0.030 |
Why?
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 4 | 0.030 |
Why?
| Models, Molecular | 1 | 2020 | 1390 | 0.030 |
Why?
| Energy Metabolism | 1 | 2020 | 715 | 0.030 |
Why?
| Proteomics | 1 | 2021 | 859 | 0.030 |
Why?
| Blood | 1 | 2015 | 97 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2015 | 99 | 0.030 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 208 | 0.030 |
Why?
| Genes, Suppressor | 1 | 2014 | 4 | 0.030 |
Why?
| Protein Isoforms | 1 | 2016 | 339 | 0.030 |
Why?
| Corpus Callosum | 1 | 2014 | 57 | 0.030 |
Why?
| Coculture Techniques | 1 | 2015 | 202 | 0.030 |
Why?
| Killer Cells, Natural | 1 | 2017 | 383 | 0.030 |
Why?
| Transfection | 1 | 2016 | 866 | 0.030 |
Why?
| Eosinophils | 1 | 2016 | 282 | 0.030 |
Why?
| Autoimmunity | 1 | 2020 | 822 | 0.030 |
Why?
| Catalytic Domain | 1 | 2015 | 202 | 0.030 |
Why?
| Computer Simulation | 1 | 2018 | 884 | 0.030 |
Why?
| Nucleosomes | 1 | 2015 | 125 | 0.030 |
Why?
| Precipitin Tests | 2 | 2004 | 90 | 0.030 |
Why?
| Virus Replication | 1 | 2016 | 396 | 0.030 |
Why?
| Membrane Transport Proteins | 1 | 2015 | 137 | 0.030 |
Why?
| RNA Editing | 1 | 2014 | 20 | 0.030 |
Why?
| Cell Death | 1 | 2015 | 326 | 0.030 |
Why?
| Neurogenesis | 1 | 2014 | 102 | 0.030 |
Why?
| RNA Isoforms | 1 | 2013 | 1 | 0.030 |
Why?
| Lung | 2 | 2018 | 3673 | 0.030 |
Why?
| HapMap Project | 1 | 2013 | 3 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 1153 | 0.030 |
Why?
| Toll-Like Receptor 5 | 1 | 2013 | 14 | 0.030 |
Why?
| Ataxins | 1 | 2013 | 3 | 0.030 |
Why?
| Ataxin-1 | 1 | 2013 | 4 | 0.030 |
Why?
| RNA Cap-Binding Proteins | 1 | 2013 | 4 | 0.030 |
Why?
| ELAV Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| Cell Cycle | 1 | 2016 | 546 | 0.030 |
Why?
| Flagellin | 1 | 2013 | 15 | 0.030 |
Why?
| Chemokine CXCL12 | 1 | 2013 | 74 | 0.030 |
Why?
| Cytokines | 1 | 2020 | 1853 | 0.030 |
Why?
| Substrate Specificity | 1 | 2013 | 357 | 0.030 |
Why?
| NIH 3T3 Cells | 1 | 2013 | 137 | 0.030 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 286 | 0.030 |
Why?
| Acetylation | 1 | 2013 | 212 | 0.030 |
Why?
| Multigene Family | 1 | 2013 | 193 | 0.030 |
Why?
| History, 21st Century | 1 | 2013 | 162 | 0.030 |
Why?
| Codon | 1 | 2012 | 86 | 0.030 |
Why?
| Tretinoin | 1 | 2013 | 124 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2020 | 2129 | 0.030 |
Why?
| RNA Folding | 1 | 2012 | 33 | 0.030 |
Why?
| History, 20th Century | 1 | 2013 | 273 | 0.020 |
Why?
| Genetic Research | 1 | 2011 | 17 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 32 | 0.020 |
Why?
| 3T3 Cells | 1 | 2012 | 137 | 0.020 |
Why?
| Adipose Tissue, White | 1 | 2012 | 33 | 0.020 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2012 | 37 | 0.020 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 228 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2013 | 139 | 0.020 |
Why?
| Expressed Sequence Tags | 1 | 2011 | 38 | 0.020 |
Why?
| Cellular Senescence | 1 | 2013 | 153 | 0.020 |
Why?
| Data Mining | 1 | 2012 | 100 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2012 | 187 | 0.020 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2013 | 277 | 0.020 |
Why?
| Adipose Tissue, Brown | 1 | 2012 | 68 | 0.020 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 195 | 0.020 |
Why?
| Skin Diseases | 1 | 2012 | 124 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 332 | 0.020 |
Why?
| Neutrophils | 1 | 2016 | 1172 | 0.020 |
Why?
| PPAR gamma | 1 | 2012 | 185 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3471 | 0.020 |
Why?
| Gene Dosage | 1 | 2011 | 129 | 0.020 |
Why?
| Zygote | 1 | 2010 | 16 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2013 | 446 | 0.020 |
Why?
| Bias | 1 | 2011 | 179 | 0.020 |
Why?
| Lipopeptides | 1 | 2009 | 14 | 0.020 |
Why?
| Career Choice | 1 | 2011 | 183 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 235 | 0.020 |
Why?
| Poly I-C | 1 | 2009 | 52 | 0.020 |
Why?
| Mice, SCID | 1 | 2010 | 321 | 0.020 |
Why?
| Feedback, Physiological | 1 | 2009 | 73 | 0.020 |
Why?
| Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 271 | 0.020 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2009 | 49 | 0.020 |
Why?
| Toll-Like Receptors | 1 | 2009 | 166 | 0.020 |
Why?
| Random Allocation | 1 | 2009 | 337 | 0.020 |
Why?
| Models, Animal | 1 | 2010 | 350 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2009 | 110 | 0.020 |
Why?
| Lacrimal Apparatus | 1 | 2008 | 10 | 0.020 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 99 | 0.020 |
Why?
| Vacuoles | 1 | 2008 | 33 | 0.020 |
Why?
| Polyribosomes | 1 | 2008 | 23 | 0.020 |
Why?
| Salivary Glands | 1 | 2008 | 31 | 0.020 |
Why?
| Secretory Vesicles | 1 | 2008 | 24 | 0.020 |
Why?
| Leukocytes | 1 | 2009 | 281 | 0.020 |
Why?
| Oxidoreductases, N-Demethylating | 1 | 2007 | 10 | 0.020 |
Why?
| Macromolecular Substances | 1 | 2008 | 200 | 0.020 |
Why?
| Eye | 1 | 2008 | 101 | 0.020 |
Why?
| Oncogene Proteins, Fusion | 1 | 2009 | 178 | 0.020 |
Why?
| Adenosine Triphosphatases | 1 | 2008 | 155 | 0.020 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 59 | 0.020 |
Why?
| Embryo, Nonmammalian | 1 | 2007 | 173 | 0.020 |
Why?
| DNA Primers | 1 | 2008 | 514 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 1651 | 0.020 |
Why?
| Uveitis | 1 | 2006 | 115 | 0.020 |
Why?
| Actins | 1 | 2008 | 383 | 0.020 |
Why?
| Glucose | 1 | 2010 | 904 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2004 | 189 | 0.010 |
Why?
| Colforsin | 1 | 2004 | 46 | 0.010 |
Why?
| Quality Improvement | 1 | 2011 | 958 | 0.010 |
Why?
| Transcription Factor RelA | 1 | 2003 | 83 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2423 | 0.010 |
Why?
| Prognosis | 1 | 2010 | 3343 | 0.010 |
Why?
| Blood Glucose | 1 | 2010 | 1824 | 0.010 |
Why?
| Shal Potassium Channels | 1 | 2000 | 6 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 2000 | 56 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2003 | 1243 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 298 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2003 | 1137 | 0.010 |
Why?
| Middle Aged | 1 | 2010 | 27069 | 0.010 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|